Assessing patients’ risk of COVID-19 severe infection: developing a risk prediction score

Not Applicable

Completed

• Conditions: Prognosis of patients with a clinical diagnosis of Covid-19 infection; Infections and Infestations; COVID-19 (SARS-CoV-2 infection)

• Registration Number: ISRCTN13953727
• Lead Sponsor: Imperial College London

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33939619/ (added 05/05/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35909058/ Development and validation of RECAP prediction tools (added 29/08/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-02
• Study Completion: 2022-02-02
• Last Update Posted: 11 September 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 8311

Inclusion Criteria

Patients:
1. At least 18 years old
2. Seek care at their primary care centre for signs and symptoms compatible with Covid-19 infection
3. Consent for their data to be linked to hospital data (only for practices outside North West London).

Primary care practices:
1. Based in NWL CCG or belong to the RCGP Research and Surveillance Centre
2. Use SystmsOne or EMIS software

Exclusion Criteria

Primary care practice sites:
Not using a compatible electronic record system or using a remote monitoring system that cannot provide an output that is at least mapped to the appropriate SNOMED concepts

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospital admission defined as hospital stay of 24 hours or longer during the period of study measured using patient records

Secondary Outcome Measures

Name	Time	Method
1. Intensive Care Unit admission defined as admission in an intensive care unit of any length during the period of study measured using patient records<br>2. Death during the period of study measured using patient records